SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs > Arena Pharmaceuticals, Inc. (ARNA)

Conference Call?

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
hlegweakreturns Member Profile
 
Followed By 1
Posts 448
Boards Moderated 0
Alias Born 07/31/13
160x600 placeholder
Arena Pharmaceuticals to Present at the 16th Annual Needham Healthcare Conference on April 4th "PR Newswire (US)" - 3/27/2017 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 3/20/2017 5:55:12 PM
Initial Statement of Beneficial Ownership (3) "Edgar (US Regulatory)" - 3/20/2017 5:54:01 PM
Arena Pharmaceuticals Appoints Dr. Preston Klassen, M.D., M.H.S. as Executive Vice President, Research and Development and Ch... "PR Newswire (US)" - 3/20/2017 8:30:00 AM
Annual Report (10-k) "Edgar (US Regulatory)" - 3/15/2017 8:12:59 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/14/2017 4:10:04 PM
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2016 Financial Results "PR Newswire (US)" - 3/14/2017 4:01:00 PM
Arena Pharmaceuticals to Present at the 27th Annual Oppenheimer Healthcare Conference "PR Newswire (US)" - 3/8/2017 4:30:00 PM
Arena Pharmaceuticals to Provide Corporate Update and Release Fourth Quarter and Full-Year 2016 Financial Results on Tuesday,... "GlobeNewswire Inc." - 3/6/2017 4:30:00 PM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/14/2017 10:48:03 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/14/2017 9:02:33 AM
Arena Pharmaceuticals Appoints Three New Members to Board of Directors "PR Newswire (US)" - 2/14/2017 8:30:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 2/9/2017 1:06:55 PM
Schedule 13g "Edgar (US Regulatory)" - 2/9/2017 9:54:52 AM
Arena Pharmaceuticals Announces Three Upcoming Presentations at the 12th Congress of European Crohn's and Colitis Organisatio... "PR Newswire (US)" - 2/9/2017 8:30:00 AM
Amended Statement of Ownership (sc 13g/a) "Edgar (US Regulatory)" - 1/19/2017 5:30:28 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/6/2017 4:48:16 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/4/2017 4:23:47 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 1/4/2017 4:20:19 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 1/4/2017 4:16:24 PM
Arena Pharmaceuticals and Eisai Amend Marketing and Supply Agreement for BELVIQ Globally "PR Newswire (US)" - 1/4/2017 4:05:00 PM
Eisai and Arena Pharmaceuticals Announce Regulatory Approval of BELVIQ® (lorcaserin HCl) in Brazil "PR Newswire (US)" - 12/19/2016 1:30:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/16/2016 5:22:09 PM
Arena Pharmaceuticals to Present at the 35th Annual J.P. Morgan Healthcare Conference "PR Newswire (US)" - 12/13/2016 8:30:00 AM
Arena Pharmaceuticals Completes Enrollment in Ralinepag Phase 2 Clinical Trial for Pulmonary Arterial Hypertension (PAH) "PR Newswire (US)" - 12/7/2016 8:30:00 AM
SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist